Keywords
MedicineIndapamideBlood pressurePerindoprilInternal medicineMacrovascular diseaseDiabetes mellitusStroke (engine)Type 2 diabetesCardiologyPlaceboMyocardial infarctionRandomized controlled trialEndocrinology
Related Publications
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in pre...
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
In patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease, treatment with dapagliflozin did not result in a higher or lower rate of MAC...
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or ...
Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke
Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...
Publication Info
- Year
- 2007
- Type
- article
- Volume
- 370
- Issue
- 9590
- Pages
- 829-840
- Citations
- 2029
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2029
OpenAlex
Cite This
Anushka Patel
(2007).
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
The Lancet
, 370
(9590)
, 829-840.
https://doi.org/10.1016/s0140-6736(07)61303-8
Identifiers
- DOI
- 10.1016/s0140-6736(07)61303-8